FDA Approved: CEFPROZIL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Cefprozil from Teva Pharmaceuticals USA, Inc., updating labeling or indications for the antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Otitis Media
• Pharyngitis
• Sinusitis
• Skin and Skin Structure Infections
• Tonsillitis

Drugs mentioned

• Cefprozil (cefprozil)

Snippet

SUPPL AP for CEFPROZIL (CEFPROZIL)